Related Experiment Video

Updated: Aug 30, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

The regulation and consequences of immune-mediated cell death in atheromatous diseases

Jonathan C Choy1, Thomas J Podor, Bobby Yanagawa

  • 1UBC McDonald Research Laboratories/The iCAPTUR4E Centre, Department of Pathology and Laboratory Medicine, St. Paul's Hospital/ Providence Health Care, University of British Columbia, Vancouver, British Columbia, Canada.

Cardiovascular Toxicology
|October 14, 2003
PubMed

Insights

Cytotoxic immune mechanisms, including FasL and granzyme/perforin pathways, are crucial in the development of atheromatous diseases like coronary artery disease (CAD) and transplant vascular disease (TVD). This review examines their role in lesion pathogenesis.

Area of Science:

  • Immunology
  • Cardiovascular Disease
  • Pathology

Background:

  • Atheromatous diseases, including coronary artery disease (CAD) and transplant vascular disease (TVD), are inflammatory vascular disorders.
  • Cytotoxic immune mechanisms are increasingly recognized for their role in inflammatory processes.

Purpose of the Study:

  • To review the contribution of immune cell-mediated cell death to the onset and pathogenesis of CAD and TVD.
  • To explore the role of FasL and granzyme/perforin pathways in atheromatous disease development.

Main Methods:

  • Literature review focusing on immune cell-mediated cytotoxicity.
  • Analysis of the role of specific immune pathways (FasL, granzyme/perforin) in vascular lesions.

Main Results:

  • Immune cell-mediated cell death pathways are likely significant in the development and remodeling of atheromatous lesions.
  • Specific mediators and effectors suggest a shared contribution across a spectrum of atheromatous diseases.

Conclusions:

  • Cytotoxic immune mechanisms play a critical role in the pathogenesis of CAD and TVD.
  • Understanding these pathways offers insights into potential therapeutic targets for atheromatous diseases.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...